Biontech Expects 2025 Total Revenues Between EUR 1.7 BLN And EUR 2.2 BLN

Reuters

Mar 10, 2025

March 10 (Reuters) - BioNTech SE <22UAy.DE>::
*EXPECTS 2025 TOTAL REVENUES BETWEEN EUR 1.7 BILLION AND EUR 2.2 BILLION
*CASH AND CASH EQUIVALENTS PLUS SECURITY INVESTMENTS OF EUR 17.4 BILLION AS OF DECEMBER 31, 2024
*CEO - EXPECT 2025 TO BE A DATA-RICH YEAR WITH MULTIPLE IMPORTANT UPDATES FROM OUR PRIORITY PROGRAMS, WHICH WE BELIEVE HAVE DISRUPTIVE POTENTIAL AND COULD IMPROVE STANDARD OF CARE, IF SUCCESSFULLY DEVELOPED AND APPROVED
*OUTLOOK 2025: RESEARCH AND DEVELOPMENT EXPENSES EUR 2,600 MILLION - EUR 2,800 MILLION, SG&A EXPENSES EUR 650 MILLION - EUR 750 MILLION
*OUTLOOK 2025: CAPITAL EXPENDITURES FOR OPERATING ACTIVITIES EUR 250 MILLION - EUR 350 MILLION

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 10-MAR-202510:55:00.233 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2518624475"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2518624475\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2518624475?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-10 19:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2518624475","market":"nz","top_or_hot":-1,"title":"Biontech Expects 2025 Total Revenues Between EUR 1.7 BLN And EUR 2.2 BLN","media":"Reuters","content":"<html><body>March 10 (Reuters) - <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> &lt;22UAy.DE&gt;::<br/>*EXPECTS 2025 TOTAL REVENUES BETWEEN EUR 1.7 BILLION AND EUR 2.2 BILLION<br/>*CASH AND CASH EQUIVALENTS PLUS SECURITY INVESTMENTS OF EUR 17.4 BILLION AS OF DECEMBER 31, 2024<br/>*CEO - EXPECT 2025 TO BE A DATA-RICH YEAR WITH MULTIPLE IMPORTANT UPDATES FROM OUR PRIORITY PROGRAMS, WHICH WE BELIEVE HAVE DISRUPTIVE POTENTIAL AND COULD IMPROVE STANDARD OF CARE, IF SUCCESSFULLY DEVELOPED AND APPROVED<br/>*OUTLOOK 2025: RESEARCH AND DEVELOPMENT EXPENSES EUR 2,600 MILLION - EUR 2,800 MILLION,  SG&amp;A EXPENSES EUR 650 MILLION - EUR 750 MILLION<br/>*OUTLOOK 2025: CAPITAL EXPENDITURES FOR OPERATING ACTIVITIES EUR 250 MILLION - EUR 350 MILLION<br/><br/>  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))<br/>  Source Date/Time = 10-MAR-202510:55:00.233 GMT</body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biontech Expects 2025 Total Revenues Between EUR 1.7 BLN And EUR 2.2 BLN</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiontech Expects 2025 Total Revenues Between EUR 1.7 BLN And EUR 2.2 BLN\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-03-10 19:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body>March 10 (Reuters) - <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a> &lt;22UAy.DE&gt;::<br/>*EXPECTS 2025 TOTAL REVENUES BETWEEN EUR 1.7 BILLION AND EUR 2.2 BILLION<br/>*CASH AND CASH EQUIVALENTS PLUS SECURITY INVESTMENTS OF EUR 17.4 BILLION AS OF DECEMBER 31, 2024<br/>*CEO - EXPECT 2025 TO BE A DATA-RICH YEAR WITH MULTIPLE IMPORTANT UPDATES FROM OUR PRIORITY PROGRAMS, WHICH WE BELIEVE HAVE DISRUPTIVE POTENTIAL AND COULD IMPROVE STANDARD OF CARE, IF SUCCESSFULLY DEVELOPED AND APPROVED<br/>*OUTLOOK 2025: RESEARCH AND DEVELOPMENT EXPENSES EUR 2,600 MILLION - EUR 2,800 MILLION,  SG&amp;A EXPENSES EUR 650 MILLION - EUR 750 MILLION<br/>*OUTLOOK 2025: CAPITAL EXPENDITURES FOR OPERATING ACTIVITIES EUR 250 MILLION - EUR 350 MILLION<br/><br/>  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))<br/>  Source Date/Time = 10-MAR-202510:55:00.233 GMT</body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BNTX","symbol_name":"BioNTech SE","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nRSD99nY5C:1","article_id":"2518624475","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2518624475","pubTimestamp":1741605225,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"March 10 (Reuters) - BioNTech SE <22UAy.DE>::*EXPECTS 2025 TOTAL REVENUES BETWEEN EUR 1.7 BILLION AND EUR 2.2 BILLION*CASH AND CASH EQUIVALENTS PLUS SECURITY INVESTMENTS OF EUR 17.4 BILLION AS OF DECE","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"BNTX":"BioNTech SE"},"translate_title":"Biontech预计2025年总收入在17亿欧元至22亿欧元之间","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BNTX":0.9},"content_text":"March 10 (Reuters) - BioNTech SE <22UAy.DE>::*EXPECTS 2025 TOTAL REVENUES BETWEEN EUR 1.7 BILLION AND EUR 2.2 BILLION*CASH AND CASH EQUIVALENTS PLUS SECURITY INVESTMENTS OF EUR 17.4 BILLION AS OF DECEMBER 31, 2024*CEO - EXPECT 2025 TO BE A DATA-RICH YEAR WITH MULTIPLE IMPORTANT UPDATES FROM OUR PRIORITY PROGRAMS, WHICH WE BELIEVE HAVE DISRUPTIVE POTENTIAL AND COULD IMPROVE STANDARD OF CARE, IF SUCCESSFULLY DEVELOPED AND APPROVED*OUTLOOK 2025: RESEARCH AND DEVELOPMENT EXPENSES EUR 2,600 MILLION - EUR 2,800 MILLION,  SG&A EXPENSES EUR 650 MILLION - EUR 750 MILLION*OUTLOOK 2025: CAPITAL EXPENDITURES FOR OPERATING ACTIVITIES EUR 250 MILLION - EUR 350 MILLION  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 10-MAR-202510:55:00.233 GMT","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}